跳至主要内容
临床试验/NCT02594644
NCT02594644已完成不适用

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

University of California, Davis1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年11月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Difference in the Percentage of Complete Clearance of the Actinic Keratoses

研究概览

简要总结

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

详细描述

The current standard of care of photodynamic therapy to treat actinic keratoses includes pre-treatment of the area with topical aminolevulinic acid for 1 hour, followed by treatment with blue light. In a previous study, the investigators showed pretreatment of microneedles enhance penetration of topical aminolevulinic acid as compared to the control group.

The aim of this study is to investigate how varying incubation periods of topical aminolevulinic acid after pretreatment with microneedle application can facilitate the penetration and efficacy of photodynamic therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age and older
  • Subjects has actinic keratoses and qualifies for photodynamic therapy
  • Do not meet any of the exclusion criteria

排除标准

  • Subjects who smoke
  • Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition
  • Subjects who have established allergy to topical ALA
  • Subjects who have had a documented nonmelanoma skin cancer on the face over the past 6 months

研究组 & 干预措施

10-minute Incubation with Microneedle Roller & Sham

Experimental

10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Microneedle Roller (Device)

10-minute Incubation with Microneedle Roller & Sham

Experimental

10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Aminolevulinic Acid (Drug)

10-minute Incubation with Microneedle Roller & Sham

Experimental

10-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Blue Light (Radiation)

20-minute Incubation with Microneedle Roller & Sham

Experimental

20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Microneedle Roller (Device)

20-minute Incubation with Microneedle Roller & Sham

Experimental

20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Aminolevulinic Acid (Drug)

20-minute Incubation with Microneedle Roller & Sham

Experimental

20-minute topical aminolevulinic acid incubation group. Subjects randomized by binary randomization into each treatment group and undergo secondary binary randomization for microneedle roller treatment (vs. sham microneedle) to the right or left side of the face. Blue light therapy follows.

干预措施: Blue Light (Radiation)

结局指标

主要结局

Difference in the Percentage of Complete Clearance of the Actinic Keratoses

时间窗: Baseline, 2 Months

The primary endpoint will be the difference in the percentage of complete clearance of the actinic keratoses as an intraindividual comparison between the treatment groups.

次要结局

  • Visual Analog Pain Scale(Immediately Post-Treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验